{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:02:40Z","timestamp":1787655760850,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.lfs.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T14:21:30Z","timestamp":1531837290000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects"],"prefix":"10.1016","volume":"208","author":[{"given":"Manar Gamal","family":"Helal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Mohamed Abdel Fattah","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5529-6994","authenticated-orcid":false,"given":"Eman","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2018.07.021_bb0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.lfs.2018.07.021_bb0010","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1128\/AAC.01627-08","article-title":"Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney","volume":"53","author":"Fujiwara","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/08860229209047660","article-title":"Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study","volume":"14","author":"Nonclercq","year":"1992","journal-title":"Ren. Fail."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2018.07.021_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2009.08.021","article-title":"Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats","volume":"620","author":"Li","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.07.021_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6793-7-1","article-title":"A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer","volume":"7","author":"Edwards","year":"2007","journal-title":"BMC Physiol."},{"issue":"3 Pt 2","key":"10.1016\/j.lfs.2018.07.021_bb0035","article-title":"Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli","volume":"263","author":"Duque","year":"1992","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/2229-516X.198516","article-title":"Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: an experimental study","volume":"7","author":"Kagal","year":"2017","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"10.1016\/j.lfs.2018.07.021_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4172\/2155-6156.1000414","article-title":"Type 2 diabetes treatment recommendations update: appropriate use of DPP4 inhibitors","volume":"5","author":"Cornell","year":"2014","journal-title":"J. Diabetes Metab."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0976-500X.85934","article-title":"Saxagliptin: a dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus","volume":"2","author":"Dave","year":"2011","journal-title":"J. Pharmacol. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jphs.2017.10.003","article-title":"The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: studies with HK-2 cells in vitro and normal rats in vivo","volume":"135","author":"Uchii","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2018.07.021_bb0060","article-title":"Nephroprotection with saxagliptin","volume":"32","author":"Iazzetta","year":"2015","journal-title":"G. Ital. Nefrol."},{"key":"10.1016\/j.lfs.2018.07.021_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2015.04.023","article-title":"Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats","volume":"761","author":"Sakai","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.07.021_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2016.04.005","article-title":"Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats","volume":"783","author":"Uchii","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s13300-016-0184-9","article-title":"Saxagliptin efficacy and safety in patients with type 2 diabetes and moderate renal impairment","volume":"7","author":"Perl","year":"2016","journal-title":"Diabetes Ther."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bbrc.2016.12.052","article-title":"Protective effects of hydroxytyrosol on gentamicin induced nephrotoxicity in mice","volume":"482","author":"Chashmi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.07.021_bb0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1139\/cjpp-2015-0070","article-title":"Tranilast ameliorates cyclophosphamide-induced lung injury and nephrotoxicity","volume":"94","author":"Said","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/toxsci\/kfm152","article-title":"Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys","volume":"99","author":"Peyrou","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2018.07.021_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-4274(94)03205-L","article-title":"Gentamicin-induced kidney damage and lipid peroxidation in rats","volume":"76","author":"Fauconneau","year":"1995","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1139\/cjpp-2015-0277","article-title":"Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney","volume":"94","author":"Mehrzadi","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/014556139707600310","article-title":"Mechanism and prevention of aminoglycoside ototoxicity: outer hair cells as targets and tools","volume":"76","author":"Priuska","year":"1997","journal-title":"Ear Nose Throat J."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mco.2013.202","article-title":"A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress","volume":"2","author":"Xu","year":"2014","journal-title":"Mol. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1744-9987.12504","article-title":"Role of uremic toxins on apoptosis with varying periods of hemodialysis","volume":"21","author":"Hunkerler","year":"2017","journal-title":"Ther. Apher. Dial."},{"issue":"13","key":"10.1016\/j.lfs.2018.07.021_bb0125","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1096\/fj.05-4200rev","article-title":"\u201cSimple but not simpler\u201d: toward a unified picture of energy requirements in cell death","volume":"19","author":"Chiarugi","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.lfs.2018.07.021_bb0130","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-4159.2004.02957.x","article-title":"Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death","volume":"92","author":"Steinbach","year":"2005","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.lfs.2018.07.021_bb0135","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1476-5381.2009.00432.x","article-title":"Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis","volume":"158","author":"Modis","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","article-title":"Glomerular nephrotoxicity of aminoglycosides","volume":"223","author":"Martinez-Salgado","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2018.07.021_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/phrs.1999.0494","article-title":"Protective effects of vitamin e and probucol against gentamicin-induced nephrotoxicity in rats","volume":"40","author":"Abdel-Naim","year":"1999","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2018.07.021_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/313528","article-title":"The effects of vitamin D on gentamicin-induced acute kidney injury in experimental rat model","volume":"2013","author":"Hur","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0155","first-page":"287","article-title":"Effect of normobaric hyperoxia on gentamicin-induced nephrotoxicity in rats","volume":"17","author":"Tavafi","year":"2014","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1523-1755.2004.00718.x","article-title":"Altered NMDA receptor expression in renal toxicity: protection with a receptor antagonist","volume":"66","author":"Leung","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2018.07.021_bb0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6904-4-5","article-title":"S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo","volume":"4","author":"Pedraza-Chaverri","year":"2004","journal-title":"BMC Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13105-015-0428-6","article-title":"Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib","volume":"71","author":"Elsherbiny","year":"2015","journal-title":"J. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1681\/ASN.2006060639","article-title":"Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney","volume":"18","author":"Kojima","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2006090998","article-title":"Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury","volume":"19","author":"Hill","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cvr\/cvm035","article-title":"Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha","volume":"77","author":"Cai","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.lfs.2018.07.021_bb0190","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1074\/jbc.M107525200","article-title":"Prevention of kidney ischemia\/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction","volume":"277","author":"Park","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2018.07.021_bb0195","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.lfs.2018.07.021_bb0200","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2010.88","article-title":"An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease","volume":"77","author":"Garcia-Sanchez","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2018.07.021_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4172\/2155-9880.1000249","article-title":"Effect of vildagliptin on atherosclerosis progression in high cholesterol\u2013fed male rabbits","volume":"4","author":"Hadi","year":"2013","journal-title":"J. Clin. Exp. Cardiol."},{"key":"10.1016\/j.lfs.2018.07.021_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1475-2840-13-32","article-title":"The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms","volume":"13","author":"Zeng","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"21","key":"10.1016\/j.lfs.2018.07.021_bb0215","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","article-title":"Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis","volume":"124","author":"Shah","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2018.07.021_bb0220","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1758-5996-6-42","article-title":"Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker diabetic fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties","volume":"6","author":"Mega","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"issue":"2","key":"10.1016\/j.lfs.2018.07.021_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/ars.2016.6953","article-title":"Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis","volume":"28","author":"Wang","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.lfs.2018.07.021_bb0230","article-title":"Protective effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, against cisplatin-induced nephrotoxicity in mice","volume":"2017","author":"Choi","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.lfs.2018.07.021_bb0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2014.10.007","article-title":"Saxagliptin: a novel antiparkinsonian approach","volume":"89","author":"Nassar","year":"2015","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.lfs.2018.07.021_bb0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31826be204","article-title":"Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats","volume":"60","author":"Mason","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518303989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518303989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:30:46Z","timestamp":1742376646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518303989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"alternative-id":["S0024320518303989"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.07.021","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}